JNJ Quantitative Stock Analysis

Johnson & Johnson (JNJ) received a 72% rating from Validea's Patient Investor model, which is based on Warren Buffett's strategy emphasizing long-term predictable profitability, low debt, and reasonable valuations. While JNJ passed most criteria, including earnings predictability and free cash flow, it failed on 'use of retained earnings' and 'expected return,' placing it below the 80% threshold typically indicating 'some interest' for this strategy.

Analysis

Johnson & Johnson (JNJ) rates as fundamentally sound but not compellingly valued according to Validea's Patient Investor model, which is based on Warren Buffett's investment criteria. The company scored 72%, which is below the 80% threshold that typically indicates interest from this specific strategy. JNJ demonstrates significant strengths, passing key tests for earnings predictability, debt service, return on equity, return on total capital, and free cash flow. The model also positively recognized the company's share repurchase program. However, the analysis highlights two critical weaknesses that detract from its overall score: a failure on the 'Use of Retained Earnings' and 'Expected Return' criteria. These specific failures suggest that, from the model's perspective, the company's capital allocation may not be generating sufficient value for shareholders and that its current valuation does not offer a high enough prospective rate of return to meet the strict standards of the Buffett-based approach.

Key Decisions for Investors

• Investors applying a strict Buffett-style value discipline should exercise caution, as the model's failure on 'Expected Return' and 'Use of Retained Earnings' indicates potential valuation headwinds despite the company's strong underlying business quality.
• For investors focused on quality and stability, JNJ's demonstrated strengths in earnings predictability, free cash flow generation, and low debt could justify its inclusion as a core holding, even if it doesn't meet the rigorous valuation criteria of this specific model.
• Monitor future capital allocation announcements and earnings reports closely, as any improvement in the management's use of retained earnings or a more favorable valuation could significantly alter the stock's appeal to quantitative value strategies.